rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Astellas Pharma

Rediff.com  »  News  »   Astellas Pharma

  News for Astellas Pharma

  • Business

Japanese pharma firm sets up Indian subsidiary

Astellas Pharma, the second largest Japanese drug company, has set up a wholly-owned subsidiary in India, making it the third Japanese pharma major after Daiichi Sankyo and Eisai to tap the growing......

Glenmark gets USFDA nod for skin infections cream

Glenmark Pharmaceuticals said on Monday it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections. Glenmark......

US stops launch of Dr Reddy's drug

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis'......

Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008.This increase is despite......

It's destination India for Japan Inc!

India has become the most sought destination for investment by Japanese companies, next to China, and ahead of other Asian countries and emerging economies like Russia, Brazil, Mexico and even the......
  Web results for Astellas Pharma
Vical Announces Completion of Enrollment in Phase 2 Clinical Trial of Investigational CMV Vaccine in Kidney Transplant Recipients

GlobeNewswire 2015-05-21SAN DIEGO, May 21, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the completion of enrollment... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=72133
PM360 Announces Winners Of The First Annual ELITE Awards

/PRNewswire/ -- PM360 , a leading health-marketing industry trade magazine, has announced the winners of its inaugural ELITE awards. The ELITE ( E... ...

http://in.advfn.com/p.php?pid=nmona&article=66929038
DIFICLIR[TM]▼ (Fidaxomicin) Significantly Reduces Recurrence and All-Cause Mortality When Used First-Line in all..

DIFICLIR[TM]▼ (Fidaxomicin) Significantly Reduces Recurrence and All-Cause Mortality When Used First-Line in all Patients W... BLED, Slovenia,... ...

http://in.advfn.com/p.php?pid=nmona&article=66929224
Global Multiple Myeloma Drug Market & Pipeline Insight

/PRNewswire/ -- Dublin - Research and Markets (http://www.researchandmarkets.com/research/bv3584/global_multiple) has announced the addition of... ...

http://in.advfn.com/p.php?pid=nmona&article=66929186
Astellas presents positive results from phase 3b BESIDE trial of solifenacin with mirabegron as an add-on therapy to treat OAB at AUA meeting

Astellas Pharma Inc. announced results from its phase 3b BESIDE clinical trial demonstrated solifenacin (SOLI) with mirabegron (MIRA) as an add-on... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=88303&sid=2

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


astellas pharma
Astellas Pharma

Company
0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z